U.S. Physical Therapy (USPH) Competitors

U.S. Physical Therapy (NYSE:USPH) and Veracyte (NASDAQ:VCYT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation, analyst recommendations and community ranking.

Is USPH or VCYT more profitable?

U.S. Physical Therapy has a net margin of 4.67% compared to Veracyte's net margin of -20.61%. U.S. Physical Therapy's return on equity of 8.52% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
U.S. Physical Therapy	4.67%	8.52%	3.92%
Veracyte	-20.61%	-2.02%	-1.89%

Which has higher valuation and earnings, USPH or VCYT?

U.S. Physical Therapy has higher revenue and earnings than Veracyte. Veracyte is trading at a lower price-to-earnings ratio than U.S. Physical Therapy, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
U.S. Physical Therapy	$604.80M	2.68	$28.24M	$1.35	79.62
Veracyte	$361.05M	4.45	-$74.40M	-$1.03	-20.41

Do analysts recommend USPH or VCYT?

U.S. Physical Therapy presently has a consensus price target of $125.67, suggesting a potential upside of 16.94%. Veracyte has a consensus price target of $29.00, suggesting a potential upside of 37.96%. Given Veracyte's higher possible upside, analysts clearly believe Veracyte is more favorable than U.S. Physical Therapy.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
U.S. Physical Therapy	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Veracyte	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Does the MarketBeat Community favor USPH or VCYT?

Veracyte received 184 more outperform votes than U.S. Physical Therapy when rated by MarketBeat users. Likewise, 72.88% of users gave Veracyte an outperform vote while only 56.04% of users gave U.S. Physical Therapy an outperform vote.

Company	Underperform	Outperform
U.S. Physical Therapy	Outperform Votes 246 56.04%	Underperform Votes 193 43.96%
Veracyte	Outperform Votes 430 72.88%	Underperform Votes 160 27.12%

Does the media refer more to USPH or VCYT?

In the previous week, U.S. Physical Therapy had 3 more articles in the media than Veracyte. MarketBeat recorded 8 mentions for U.S. Physical Therapy and 5 mentions for Veracyte. Veracyte's average media sentiment score of 1.20 beat U.S. Physical Therapy's score of 0.64 indicating that Veracyte is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
U.S. Physical Therapy	4 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veracyte	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, USPH or VCYT?

U.S. Physical Therapy has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, Veracyte has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500.

Summary

U.S. Physical Therapy beats Veracyte on 9 of the 15 factors compared between the two stocks.